AKT1 and cancer: Binding of IL-6 to its receptor IL-6R in cancer cells activates multiple cellular signalling pathways including JAK/STAT, PI3K/Akt (25), leading to enhanced expression of a variety of promoters of tumour growth, angiogenesis and cancer progression.